LUNG Q4 2020 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10M-5.0% YoY

Gross Profit

$7M72.0% margin

Operating Income

-$9M-95.2% margin

Net Income

-$9M-94.6% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

-7.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$264M

Total Liabilities

$38M

Stockholders' Equity

$226M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$10M	-5.0%
Gross Profit	$7M	$7M	-3.5%
Operating Income	-$9M	-$4M	-118.0%
Net Income	-$9M	-$5M	-99.1%

Geographic Segments

UNITED STATES

$5M50%

EMEA

$4M42%

Asia Pacific

$841,0009%

Other International Geographical Areas

$10,0000%